PERTH: CardieX Limited has entered a new commercial partnership agreement with consumer electronics and AI company Mobvoi to jointly launch a new line of consumer smartwatch with a heart and arterial health management feature.
The partnership expands on the existing Joint Development Agreement (JDA) initiated between the companies in 2019, a news release said.
The Agreement follows on the success of the JDA which was focused on determining the feasibility of launching CardieX subsidiary ATCOR’s patented cardiovascular and consumer health features in a wearable device fitted with a PPG sensor.
Following the success of that development program under the JDA (refer ASXrelease24 April2020), the Company lodged an application for a patent for a method of extracting advanced health features and data from a PPG sensor and commenced discussions with Mobvoi surrounding the development and commercial release of a CardieX powered smartwatch.
Mobvoi is based in Beijing and is recognized as one of China’s fastest growing and most innovative Artificial Intelligence (AI), wearable, and consumer technology companies. Mobvoi is a global leader in smartwatches and consumer AI and currently has strategic partnerships in place with both Google and the Volkswagen Group.
Under the new commercial partnership agreement, CardieX and Mobvoi will jointly launch a new line of consumer smartwatch with a heart and arterial health management feature set based around ATCOR’s proprietary and globally patented SphygmoCor technology for measuring central arterial waveforms.
Under the Agreement, Mobvoi will be responsible for developing the hardware and firmware for the new smartwatch, while CardieX will integrate a proprietary Mobvoi specific algorithm feature set based on the Company’s Arty health analytics platform into the smartwatch.
As a result, the new smartwatch will be the first in the world to feature the Company’s Heart Stress, Arterial Age, Exercise Capacity (eCAP) and Arty Score with active community and AI-powered health coaching services.
These unique features are made possible through the use of CardieX subsidiary ATCOR’s new patent pending PPG based sensor technology.
The initial phase of the Agreement includes a six (6) month market release in North America of the new smartwatch targeted for Q1 calendar 2021, with Mobvoi driving commercialization in North America and CardieX holding distribution rights in Australia, New Zealand and non-competitive channels in North America.
The launch of the Mobvoi smartwatch coincides with CardieX’s recent launch of ATCOR·X (www.atcorx.com), a new division focused on the development and licensing of cardiovascular algorithms to wearable and connected fitness companies.
Craig Cooper, CEO & Managing Director of CardieX commented: “I’m excited to be moving into commercial production of our first wearable device partnership with one of the global leaders in smartwatches and consumer AI technology.
“This is the first of many wearable integrations planned for our Arty health analytics platform which represents some of the most advanced cardiovascular and consumer wearable applications available on the market today.
“Our partnership with Mobvoi sees a select feature set of our Arty health analytics platform incorporated into a new smartwatch that was specifically designed to integrate our advanced health features. The new smartwatch will feature a revolutionary new sensor-based data extraction method based on our recently announced patent application for wearable sensor technology.
“Going forward however, we expect to be able to offer wearable data and analytics around multiple disorders, specifically those related to vascular diseases such as Alzheimer’s, as well as more advanced consumer fitness analytics”.
Mobvoi is one of China’s most innovative AI, wearable, and tech companies. Their products include the Tic Watchline of smartwatches, the Tic Home Mini smart speaker and Tic Pods Free true wireless earbuds.
Leave a Reply